AAAAAA

   
Results: 1-13 |
Results: 13
IS STEROID-RECEPTOR PROFILE IN CONTRALATERAL BREAST-CANCER A MARKER OF INDEPENDENCE OF THE CORRESPONDING PRIMARY TUMOR
Authors: CORADINI D ORIANA S MARIANI L MICELI R BRESCIANI G MARUBINI E DIFRONZO G
Citation: D. Coradini et al., IS STEROID-RECEPTOR PROFILE IN CONTRALATERAL BREAST-CANCER A MARKER OF INDEPENDENCE OF THE CORRESPONDING PRIMARY TUMOR, European journal of cancer, 34(6), 1998, pp. 825-830
5-YEAR RESULTS OF COMBINED-MODALITY APPROACH IN LOCALLY ADVANCED BREAST-CANCER (LABC) - ANALYSIS OF PROGNOSTIC FACTORS
Authors: ZAMBETTI M QUATTRONE P VERDERIO P ORIANA S VALAGUSSA P TERENZIANI M ZUCALI R BONADONNA G
Citation: M. Zambetti et al., 5-YEAR RESULTS OF COMBINED-MODALITY APPROACH IN LOCALLY ADVANCED BREAST-CANCER (LABC) - ANALYSIS OF PROGNOSTIC FACTORS, European journal of cancer, 34, 1998, pp. 70-70
RECEPTOR STATUS VARIATION IN PRIMARY BREAST-CANCER AND SUBSEQUENT ACCESSIBLE RELAPSE
Authors: CORADINI D ORIANA S DITTO A BRESCIANI G DIFRONZO G
Citation: D. Coradini et al., RECEPTOR STATUS VARIATION IN PRIMARY BREAST-CANCER AND SUBSEQUENT ACCESSIBLE RELAPSE, International journal of oncology, 8(5), 1996, pp. 997-1002
GENE-EXPRESSION OF DNA-TOPOISOMERASE- I, DNA-TOPOISOMERASE-II-ALPHA AND DNA-TOPOISOMERASE-II-BETA AND RESPONSE TO CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA
Authors: CORNAROTTI M CAPRANICO G BOHM S ORIANA S SPATTI GB MARIANI L BALLABIO G ZUNINO F
Citation: M. Cornarotti et al., GENE-EXPRESSION OF DNA-TOPOISOMERASE- I, DNA-TOPOISOMERASE-II-ALPHA AND DNA-TOPOISOMERASE-II-BETA AND RESPONSE TO CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA, International journal of cancer, 67(4), 1996, pp. 479-484
A COMPARATIVE-STUDY OF P53 GENE-MUTATIONS, PROTEIN ACCUMULATION, AND RESPONSE TO CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA
Authors: RIGHETTI SC DELLATORRE G PILOTTI S MENARD S OTTONE F COLNAGHI MI PIEROTTI MA LAVARINO C CORNAROTTI M ORIANA S BOHM S BRESCIANI GL SPATTI G ZUNINO F
Citation: Sc. Righetti et al., A COMPARATIVE-STUDY OF P53 GENE-MUTATIONS, PROTEIN ACCUMULATION, AND RESPONSE TO CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA, Cancer research, 56(4), 1996, pp. 689-693
AN ITMO GROUP-STUDY ON 2ND-LINE TREATMENT IN ADVANCED EPITHELIAL OVARIAN-CANCER - AN ATTEMPT TO IDENTIFY CLINICAL AND BIOLOGICAL FACTORS DETERMINING PROGNOSIS
Authors: DILEO A BAJETTA E BIGANZOLI L BOHM S MARIANI L MENARD S PILOTTI S FABBIANI M GEBBIA V ORIANA S OTTONE F RIBOLDI G SAVA C SPATTI G ZUNINO F DIRE F
Citation: A. Dileo et al., AN ITMO GROUP-STUDY ON 2ND-LINE TREATMENT IN ADVANCED EPITHELIAL OVARIAN-CANCER - AN ATTEMPT TO IDENTIFY CLINICAL AND BIOLOGICAL FACTORS DETERMINING PROGNOSIS, European journal of cancer, 31A(13-14), 1995, pp. 2248-2254
MITOXANTRONE AND IFOSFAMIDE AS 2ND-LINE THERAPY OF EPITHELIAL OVARIAN-CANCER - A PILOT-STUDY BY THE ITMO GROUP
Authors: DILEO A BAJETTA E BIGANZOLI L BOHM S LUPI G ORIANA S RIBOLDI G SPATTI G ZUNINO F DIRE F
Citation: A. Dileo et al., MITOXANTRONE AND IFOSFAMIDE AS 2ND-LINE THERAPY OF EPITHELIAL OVARIAN-CANCER - A PILOT-STUDY BY THE ITMO GROUP, European journal of cancer, 30A(14), 1994, pp. 2188-2188
AN INTENSIVE TREATMENT WITH MITOXANTRONE AND IFOSFAMIDE IN 2ND-LINE THERAPY OF EPITHELIAL OVARIAN-CANCER
Authors: DILEO A BIGANZOLI L BOHM S LUPI G ORIANA S RIBOLDI G SPATTI G VICARIO G DIRE F BAJETTA E
Citation: A. Dileo et al., AN INTENSIVE TREATMENT WITH MITOXANTRONE AND IFOSFAMIDE IN 2ND-LINE THERAPY OF EPITHELIAL OVARIAN-CANCER, Tumori, 80(6), 1994, pp. 443-447
CONTROL OF NAUSEA AND VOMITING BY GRANISETRON IN OVARIAN-CANCER PATIENTS TREATED WITH DIFFERENT CISPLATIN-BASED REGIMENS
Authors: BRESCIANI G BOHM S ORIANA S
Citation: G. Bresciani et al., CONTROL OF NAUSEA AND VOMITING BY GRANISETRON IN OVARIAN-CANCER PATIENTS TREATED WITH DIFFERENT CISPLATIN-BASED REGIMENS, Tumori, 80(5), 1994, pp. 344-347
GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER - CLINICAL AND ENDOCRINE EVALUATION OF RESPONSIVE PATIENTS
Authors: BAJETTA E ZILEMBO N BUZZONI R CELIO L ZAMPINO MG COLLEONI M ORIANA S ATTILI A SACCHINI V MARTINETTI A
Citation: E. Bajetta et al., GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER - CLINICAL AND ENDOCRINE EVALUATION OF RESPONSIVE PATIENTS, Oncology, 51(3), 1994, pp. 262-269
THE INTRAMUSCULAR ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO CHEMOTHERAPY IN PRETREATED OVARIAN-CANCER PATIENTS - AN ITALIAN-TRIALS-IN-MEDICAL-ONCOLOGY (ITMO) GROUP PILOT-STUDY
Authors: DILEO A BAJETTA E NOLE F BIGANZOLI L FERRARI L ORIANA S RIBOLDI G BOHM S SPATTI G RASPAGLIESI F DIRE E FONTANELLI R TAIANA A ZANON P ZUNINO F DIRE F
Citation: A. Dileo et al., THE INTRAMUSCULAR ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO CHEMOTHERAPY IN PRETREATED OVARIAN-CANCER PATIENTS - AN ITALIAN-TRIALS-IN-MEDICAL-ONCOLOGY (ITMO) GROUP PILOT-STUDY, British Journal of Cancer, 69(5), 1994, pp. 961-966
IN-VITRO CYTOTOXIC ACTIVITY OF TAXOL(R) AND TAXOTERE ON PRIMARY CULTURES AND ESTABLISHED CELL-LINES OF HUMAN OVARIAN-CANCER
Authors: SILVESTRINI R ZAFFARONI N ORLANDI L ORIANA S
Citation: R. Silvestrini et al., IN-VITRO CYTOTOXIC ACTIVITY OF TAXOL(R) AND TAXOTERE ON PRIMARY CULTURES AND ESTABLISHED CELL-LINES OF HUMAN OVARIAN-CANCER, Stem cells, 11(6), 1993, pp. 528-535
URINARY TESTOSTERONE AS A MARKER OF RISK OF RECURRENCE IN OPERABLE BREAST-CANCER
Authors: BALLERINI P ORIANA S DUCA P MARTINETTI A VENTURELLI E FERRARI L DOLCI S SECRETO G
Citation: P. Ballerini et al., URINARY TESTOSTERONE AS A MARKER OF RISK OF RECURRENCE IN OPERABLE BREAST-CANCER, Breast cancer research and treatment, 26(1), 1993, pp. 1-6
Risultati: 1-13 |